Source - RNS
RNS Number : 6828G
Hikma Pharmaceuticals Plc
31 May 2017
 

 

Hikma Pharmaceuticals PLC - Vesting of LTIP Awards

 

LONDON, 31 May 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 29 May 2017 under the 2005 Long Term Incentive Plan ("LTIP") which was completed on 31 May 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is £nil.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Chairman and Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 29 May 2017 under the 2005 LTIP.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 52,164

d)

Aggregated information

N/A

e)

Date of the transaction

30 May 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 29 May 2017 under the 2005 LTIP.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 38,088

d)

Aggregated information

N/A

e)

Date of the transaction

30 May 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

                                                                 

 

 

 

 

                                                     

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGIGDULXXBGRB